4
Changes in Ownership
IONIS PHARMACEUTICALS INC Filed Acc 0000874015-26-000161
Director sold 22,321 shares at an average $75.55 ($1,686,302)
- Director acquired 22,321 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
KLEIN JOSEPH III · Director
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-01 | Exercise or conversion : show line 1 in the form 10b5-1 | +12,000 | $38.06 | $456,720 | 23,014 | D |
| 2026-04-01 | Exercise or conversion : show line 2 in the form 10b5-1 | +10,321 | $41.08 | $423,987 | 33,335 | D |
| 2026-04-01 | Sale : show line 3 in the form 10b5-1 | −20,105 | $75.50 | $1,517,988 | 13,230 | D |
| 2026-04-01 | Sale : show line 4 in the form 10b5-1 | −2,216 | $75.95 | $168,314 | 11,014 | D |
| Open-market sales · 22,321 sh · avg $75.55 · $1,686,302 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-01 | Exercise or conversion : show line 5 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −12,000 | 0 | D |
| 2026-04-01 | Exercise or conversion : show line 6 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −10,321 | 0 | D |
Loading xslF345X06/edgardoc.xml…